July 2020
SAFETY OBSERVER N169
22 PAGES
COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
PUBLICATIONS / NUMBER 169
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Back issues
Safety Observer 173EU Clinical Trial Regulation
New FDA Draft Guidance
PV in the COVID-19 era
Product Safety News
Safety Observer 172EMA issues Q&As on DMC
New CTFG contraception guidance
MedDRA PtC Companion Document
Brexit Guidance updated
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
